A new Collaborative Research Center investigates the mechanisms of autoimmune diseases and innovative cell-based therapies Autoimmune diseases often follow a relapsing course: periods without signs of disease are interrupted by flare-ups, despite significant advances in treatment. Why these relapses occur…
How can inflammation of the skin spread to the joints?
A research group at the Department of Medicine 3, Uniklinikum Erlangen, FAU Erlangen–Nürnberg, has identified a mechanism that explains how psoriasis can extend beyond the skin to involve the joints. For the first time, the team (Maria Gabriella Raimondo, Andreas…
An Immersive VR Patient Journey – CAR-T cell Therapy
Understanding what happens inside the body empowers patients to make more confident decisions. When patients truly grasp complex mechanisms, adherence increases – and innovative therapies can be implemented more safely and efficiently. Together with Norwin Kandera (onliveline.nxt GmbH), we created…
ACR 2025 – Chicago: What a fantastic congress!
Over the rooftops of Chicago, our team from Department of Medicine 3 – Rheumatology and Immunology, Universitätsklinikum Erlangen reflected on inspiring days full of exchange, ideas, and innovation. From B-cell depleting strategies to the vision of tailored medicine, discussions at…


